showed that the methylation of two or more genes (p16, CDH13, RASSF1A, and APC) in tumor tissues and mediastinal lymph nodes of patients with curatively resected stage I NSCLC was associated with a lower 5-year RFS than methylation of fewer than two genes 10. The gene discussed is RASSF1; the disease is neoplasm.